A pilot study of safety, effectiveness, and adherence of lamivudine/zidovudine and efavirenz (3TC/ZDV + EFV) to treat HIV-1 infection in Senegal.

Trial Profile

A pilot study of safety, effectiveness, and adherence of lamivudine/zidovudine and efavirenz (3TC/ZDV + EFV) to treat HIV-1 infection in Senegal.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Sep 2013

At a glance

  • Drugs Efavirenz (Primary) ; Lamivudine/zidovudine (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top